Life sciences and health tech news roundup: Cancer care, layoffs, fundings, more

The week in existence sciences in the Pacific Northwest finished with an announcement decades in the building: The UW and Fred Hutch tightened their romance to additional closely integrate most cancers care and research.

With a larger sized umbrella, Fred Hutchinson Cancer Research Heart has a new identify: Fred Hutchinson Most cancers Center. The agreement also requires a re-structured relationship with Seattle Children’s.

The new arrangement will better hook up the lab and the clinic, tighten collaborative relationships and, pace scientific trials—which will benefit people, but also has the possible to foster new spinouts in Seattle.

And there is a new Fred Hutch spinout in city, Affini-T Therapeutics, which recently raised $175 million. In an interview, Fred Hutch researcher Phil Greenberg shared his feelings with GeekWire about doing work correctly with his new industry associate.

Much more headlines beneath, together with well being tech news about a Seattle startup’s new partnership with Yelp.  

— Biotech vet Phil Greenberg on his new cancer-fighting startup and immunotherapy’s subsequent phase

— Yelp expands health and fitness ratings for dining establishments, with assistance from Seattle startup

— Silverback Therapeutics shuts down oncology method, plans to lay off 27% of workforce

— Funding Information: Enzyme style startup lands $33M habit recovery firm raises $3M

— Most current drama at Athira: Investor calls for CEO replacement and desires two board seats

Here’s other lifetime sciences information from across the Pacific Northwest and beyond:

• Much more than 20 a long time following the to start with headlines lauding the completion of the human genome, it is eventually completed. The “dark” portions of the sequence, its extra obscure sections — centromeres, telomeres, names acquainted to the devoted — are entire. Its fleet of repetitive DNA is performed. Geneticist Evan Eichler and other UW scientists aided lead the work. Seattle’s Institute for Programs Biology also contributed.
• Amazon Web Services released a collaboration with Raleigh-Durham, N.C.-based Thread Study to decentralize scientific trials and make them extra efficient.
• Impel Neuropharma’s commercial launch of its freshly-accepted migraine remedy was “effective,” the business claimed in its newest earnings report. The organization also not too long ago pulled in $100 million in new funding to shift the solution ahead.
• Bothell, Wash.-centered Seagen is increasing. The firm posted a 38% improve in solution gross sales around past year, reaching $1.4 billion.
• AGC Biologics, also Bothell-primarily based, is generating materials for a vaccine versus peanut allergy. The drug manufacturer will make the product or service at its Heidelberg facility with its biotech companion.
• Fred Hutch researchers Jesse Bloom and Tyler Starr reviewed how the COVID-19 virus is probably to evolve in the long term, in a commentary in the New York Occasions with their colleagues.
• Vancouver, Clean.-dependent Cytodyn is in difficulties with the Food and drug administration (it’s occurred just before). The company has place scientific holds on two of its clinical trials, for HIV and COVID-19.
• Village Attain was aspect of a latest tranche of gifts by billionaire Seattle philanthropist MacKenzie Scott. The Seattle nonprofit gained $20 million to advance its function providing COVID-19 vaccines and other well being companies to less than-reached communities.
• Very long time Seattle biotech journalist and adventurer Luke Timmerman still left on his latest quest: Trekking to Everest foundation camp with a host of lifetime science leaders to increase funds for Fred Hutch.